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ABSTRACT
Objective: Compare the hepatoprotective activity of Acanthospermum hispidum ethanolic extract (AHEE) and herbal niosomal suspension (HNS) 
against hepatotoxicity.
Methods: AHEE and HNS were investigated against hepatotoxicity produced by administering a combination of four anti-tubercular drugs (ATDs) 
isoniazid (27 mg/kg), rifampin (40 mg/kg), pyrazinamide (66 mg/kg), and ethambutol (53 mg/kg) for the period of 28 days by oral route in rats. 
AHEE (400 mg/kg) and HNS (400 mg/kg) were administered along with 1 hr prior administration of ATDs once daily to five groups (six animals 
per group) of Albino Wistar rats weighing about 150-200 g. Silymarin was used as a standard drug (100 mg/kg p.o.). Liver biomarkers such as 
serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase, alkaline phosphatase, total bilirubin, and total protein were elevated 
indicating the induction of hepatotoxicity in experimental animals.
Results: The AHEE and HNS prevented the hepatotoxic effects of the combination of isoniazid, rifampin, pyrazinamide, and ethambutol on the above 
serum parameters. Histopathological studies of liver and liver biomarker estimations also supported the hepatoprotective effect of AHEE and HNS.
Conclusion: The protective effect of HNS was found to be significant when compared to standard and AHEE.
Keywords: Hepatoprotective, Acanthospermum hispidum, Isoniazid, Silymarin, Herbal niosomal suspension.
INTRODUCTION
Hepatotoxicity as injury to the liver that is allied with diminished 
liver function. The drug-induced liver injury may account for as 
many as 10% of hepatitis cases in overall adults, in adults over 
50-year-old hepatitis case 40% and 25% cases of severe liver 
failure. A higher risk of hepatotoxicity has been reported in Indian 
patients than in their Western counterparts [1,2]. The risk of 
hepatotoxicity based on data from four prospective Indian studies 
was 11.5% compared with 4.3% in Western publications [3]. In 
Western countries, paracetamol represents the first cause of all liver 
failures, but it accounts only for 25-40% cases of fulminant hepatic 
failure [4]. Anti-tubercular drugs (ATDs) are the second common 
cause of drug-induced hepatotoxicity. AT drugs are the commonest 
agents causing serious, clinically significant drug-induced acute 
liver failure in India. The most common used ATDs such as Isoniazid, 
rifampicin, pyrazinamide, and ethambutol are reported to be 
hepatotoxic [5-13]. The underlying mechanism of ATD-induced 
hepatotoxicity and the factors predisposing to its development are 
not clearly understood [14].
Acanthospermum hispidum, (family Compositae) commonly known 
as Palleru (Telugu) is found in India. The plant is used in traditional 
medicine for the treatment of constipation, fever, jaundice, malaria, 
stomachache [15], and viral infections [16]. The plant has been 
reported for its hepatoprotective activity [17], antimicrobial 
activity [18], antiplasmodial activity [19], antidiarrheoal activity [20], 
antitumor activity [21], antidiabetic activity, and anthelmintic [22]. 
So, the present study was aimed at formulating a niosomal 
suspension of A. hispidum ethanolic extract (AHEE) and comparing its 
hepatoprotective effect with AHEE and Silymarin (standard drug) in 
ATD-induced hepatotoxicity in rats.
METHODS
Drugs
Silymarin was procured from Sigma-Aldrich Pvt. Ltd, (India). Isoniazid, 
rifampicin, pyrazinamide, and ethambutol were procured from 
Lupin Ltd. India and all other chemicals and reagents used were of 
analytical grade, procured from standard deviation fine chemicals 
Ltd, (India). Serum glutamic pyruvic transaminase (SGPT), serum 
glutamic oxaloacetic transaminase (SGOT), alkaline phosphatase (ALP), 
total bilirubin, and total protein estimation kits were procured from 
Kamineni Life Sciences Pvt. Ltd. (India).
Animals
Albino Wistar rats of both the sexes (150-180 g) obtained from 
animal house of Sree Vidyanikethan College of Pharmacy were used. 
The animals were housed under standard environmental conditions 
(22±5°C with 12 hrs of light/dark cycle) and fed with commercial rat 
feed (Lipton India Ltd., Mumbai, India) and boiled water, ad libitum. All 
animal experimental protocols were approved by Institutional Animal 
Ethical Committee (SVCP/IAEC/I-020/2013-2014).
Plant material
The plant A. hispidum was collected from Tirumala hills, Andhra Pradesh, 
India. The taxonomical identification and authentication of the plant 
was done by Dr. K. Madhava Chetty, Assistant Professor, Department of 
Botany, S. V. University, Tirupathi, Andhra Pradesh, India. The voucher 
specimen was deposited at the department for future reference. The 
aerial parts of the plant were dried under the shade, powdered and 
passed through 40-mesh sieve.
Extraction of plant material
The 500 g of dried powder was extracted in soxhlet apparatus using 
ethanol as a solvent. The extract was concentrated on a rotary flash 
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evaporator to semisolid consistency and then dried over a water bath. 
The yield of the extract obtained was 72 g.
Preparation of niosomal suspension
Herbal niosomes are prepared by ether injection method using 
nonionic surfactant and cholesterol. Cholesterol and surfactant were 
dissolved in 10 ml diethyl ether mixed with 10 ml ethanol containing 
weighed quantity of herbal extract as tabulated in table. The resulting 
solution was slowly injected using syringe at a rate of 1 ml/minute into 
20 ml of hydrating solution phosphate buffer (pH 7.4). The solution 
was stirred continuously on magnetic stirrer and temperature was 
maintained at 60-65°C. As the lipid solution was injected slowly into the 
aqueous phase, the differences in temperature between phase cause 
rapid vaporization of ether, resulting in spontaneous vesiculation and 
formation of niosomes [23,24].
Acute toxicity studies
Acute toxicity studies were performed for AHEE and herbal niosomal 
suspension (HNS) according to OECD guidelines 423. Ten mice were 
selected for the study and oral administration of AHEE and HNS at a dose 
of 5, 50, 300, 2000 mg/kg given at 48 hrs interval simultaneously. In this 
toxic study, animals were observed for any changes in consumption of food 
and water, body weight, behavioral changes, and mortality rates [25,26].
Study protocol
Hepatotoxicity was induced by using isoniazid (H) (27 mg/kg, p.o), 
rifampicin (R) (40 mg/kg, p.o), pyrazinamide (Z) (66 mg/kg, p.o) and 
ethambutol (E) (53 mg/kg, p.o) for 28 days and silymarin (100 mg/kg, p.o) 
was used as the standard. The oral doses of ATDs were extrapolated 
from daily human dose using the conversion table based on body 
surface area [27].
Experimental procedure
Experimental animals were randomly divided into 5 groups, each group 
containing 6 animals and the treatment schedule for 28 days as follows.
Group I: Control (0.9% normal saline 1 ml/kg, p.o),
Group II: Toxic control (ATDs - H, R, Z, E, p.o.),
Group III:  Silymarin (100 mg/kg, p.o) + administration of ATDs after 
1 hr,
Group IV:  Ethanolic extract of A. hispidum (400 g/kg, p.o) + 
administration of ATDs after 1 hr and
Group V:  HNS (400 g/kg, p.o) + administration of ATDs after 
1 hr. On 29th day, blood is collected for estimation of 
the liver biomarker enzymes. On an equivalent day, the 
liver is removed and keeps in 10% formalin solution for 
processing of histopathological studies.
Estimation of biochemical parameters
SGOT and SGPT were estimated by Reitman and Frankel method; ALP 
was estimated by kind King’s method. Total bilirubin and total protein 
were estimated by Jendrassik and Grofs method and cholesterol 
oxidase/peroxidases method, respectively [28-31].
Histopathological studies
The livers from rats were fixed in 10% neutral formalin solution, 
dehydrated in alcohol and embedded in paraffin. Fine sections obtained 
were mounted on glass slides and counter-stained with hematoxylin 
and eosin for light microscopic analyses.
Statistical analysis
The results are presented as mean ± standard error of mean (n=6 in 
each group). Analyses were performed using One-way ANOVA followed 




The ethanolic extract of A. hispidum and HNS were found to be 
safe since no animal died even at the dose of 2000 mg/kg when 
administered orally, and the animals did not show any gross 
behavioral changes.
Biochemical parameters
Animals treated with ATDs (toxic control) showed significantly 
elevated levels of SGOT, SGPT, ALP, total bilirubin, and total protein 
levels when compared to control group. A. hispidum and HNS 
400 mg/kg given with 1 hr prior administration of ATDs showed 
significant decreased serum diagnostic liver enzymes when compared 
to toxic control (Table 1).
Histopathological studies of liver
Hepatic control group animals showed significant liver cell necrosis 
compared to normal control group. HNS 400 mg/kg showed protective 
effect on the hepatocellular necrosis and their lobular structure was 
normal when compared to A. hispidum extract (Figs. 1-5).
DISCUSSION
Hepatotoxicity of ATDs is a serious adverse drug reaction because 
it causes significant morbidity and mortality. Isoniazid, rifampicin, 
pyrazinamide, and ethambutol are potentially hepatotoxic, when given 
Table 1: Estimation of biochemical parameters in rats




Control 35.02±0.0654 36.87±0.3180 45.20±0.3416 0.3325±0.0090 5.283±0.1078
Toxic control (ATDs) 171.8±2.027# 183.6±0.888# 122.8±0.8891# 1.257±0.0117# 3.30±0.10
Silymarin+ATDs 83.92±0.2386*** 82.62±0.7947** 93.90±0.7765*** 0.438±0.0069** 4.252±0.0166***
Plant extract (400 mg)+ATDs 124.2±1.356* 139.3±0.9062* 134.1±0.5498** 0.640±0.0088* 3.385±0.0133*
Herbal niosomal suspension (400 mg)+ATDs 112.6±2.823** 72.08±0.8076** 156.1±1.427*** 0.399±0.0036* 4.642±0.0153**
Data are expressed as mean±SEM (n=6), One-way ANOVA Dunnet’s multiple comparison tests; #p≤0.05 versus control (Group I); *p≤0.05 versus toxic control (Group II); 
**p≤0.01 versus toxic control (Group II); ***p≤0.001 versus toxic control (Group II), SGOT: Serum glutamic oxaloacetic transaminase, SGPT: Serum glutamic pyruvic 
transaminase, ALP: Alkaline phosphatase, SEM: Standard error of the mean, ATDs: Anti-tubercular drugs
Fig. 1: Control (normal saline 1 ml/kg)
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in combination their toxic effects are increased [32]. In the present 
study, the combination of ATDs was used to induce hepatotoxicity in 
rats [12].
As shown in Table 1, daily administration of ATDs (HRZE) for 28 days 
result in hepatic injury as confirmed by elevated levels of serum 
diagnostic enzymes such as SGOT, SGPT, and ALP levels. In toxic control 
animals observed depletion may be due to increased utilization of 
ATDs. At the time of hepatic injury, these enzymes leak out from liver 
into the blood circulation due to liver tissue damage. The treatment 
of AHEE and HNS, the levels of these liver marker enzymes in serum 
were near to normal, this may be a consequence of the stabilization of 
plasma membrane, as well as repair of hepatic tissue damage caused 
by ATDs. Hepatotoxicity is characterized by cirrhotic liver condition 
which in turn increases the bilirubin release [33]. The treatment of 
AHEE and HNS restored the level of bilirubin to near normal may be 
due to the inhibitory effect on mitochondrial enzymes responsible 
for the metabolism of ATDs. ATDs cause cellular damage through 
the induction of oxidative stress, a consequence of dysfunction of 
the hepatic antioxidant defense system. The depletion of antioxidant 
defenses or rise in free radical production deteriorates the pro-
oxidant, antioxidant balance, leading to oxidative stress-induced cell 
death.
Histopathological observation shows AHEE and HNS have reduced 
heavy hemorrhage and hepatocellular necrosis. The treatment with 
AHEE and HNS normalized the ATDs induced histopathological changes, 
therefore, it is suggested that hepatoprotective activity of AHEE and 
HNS against ATDs induced hepatotoxicity might be due to its property 
of reducing oxidative stress.
CONCLUSION
Results obtained from the analysis of antioxidant parameters, 
biochemical parameters, and histopathological studies; it is clear 
that AHEE and HNS show hepatoprotective activity at the dose of 
400 mg/kg as compared to toxic control. Compared to AHEE - HNS 
show better results in the management of drug-induced liver toxicity.
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